Efficacy and Safety of MP-513 in Combination With Metformin in Patients With Type 2 Diabetes

NCT00971243 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

448

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: MP-513 Lowest Dose and Metformin
DRUG: MP-513 Low Dose and Metformin
DRUG: MP-513 Medium Dose and Metformin
DRUG: MP-513 High Dose and Metformin
DRUG: Placebo and Metformin

Sponsor

Tanabe Pharma Corporation